MassMutual Private Wealth & Trust’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
65,076
-1,618
-2% -$335K 0.33% 69
2026
Q1
$15M Sell
66,694
-873
-1% -$218K 0.41% 62
2025
Q4
$16.3M Sell
67,567
-1,793
-3% -$459K 0.42% 62
2025
Q3
$19M Sell
69,360
-526
-0.8% -$144K 0.48% 53
2025
Q2
$18M Buy
69,886
+1,147
+2% +$274K 0.48% 54
2025
Q1
$15.4M Buy
68,739
+2,142
+3% +$500K 0.45% 57
2024
Q4
$15.2M Buy
66,597
+1,027
+2% +$247K 0.43% 61
2024
Q3
$16M Buy
65,570
+2,454
+4% +$548K 0.46% 57
2024
Q2
$12.1M Buy
63,116
+3,365
+6% +$683K 0.37% 67
2024
Q1
$11.8M Buy
59,751
+11,030
+23% +$2.02M 0.37% 69
2023
Q4
$8.38M Sell
48,721
-7,713
-14% -$1.19M 0.28% 85
2023
Q3
$8.34M Buy
56,434
+1,849
+3% +$334K 0.31% 78
2023
Q2
$11.9M Buy
54,585
+653
+1% +$146K 0.43% 62
2023
Q1
$11.8M Buy
53,932
+976
+2% +$212K 0.45% 57
2022
Q4
$11M Sell
52,956
-1,146
-2% -$252K 0.45% 61
2022
Q3
$11.8M Buy
54,102
+992
+2% +$226K 0.54% 49
2022
Q2
$11.1M Buy
53,110
+4,187
+9% +$891K 0.48% 54
2022
Q1
$11.9M Buy
48,923
+4,158
+9% +$1.01M 0.45% 57
2021
Q4
$11.7M Buy
44,765
+2,260
+5% +$586K 0.43% 58
2021
Q3
$11.2M Buy
42,505
+3,092
+8% +$846K 0.46% 52
2021
Q2
$9.72M Buy
39,413
+3,797
+11% +$798K 0.41% 60
2021
Q1
$6.91M Buy
35,616
+2,520
+8% +$505K 0.33% 88
2020
Q4
$7.04M Buy
33,096
+592
+2% +$118K 0.36% 73
2020
Q3
$5.57M Buy
32,504
+866
+3% +$160K 0.33% 83
2020
Q2
$6.07M Buy
31,638
+492
+2% +$80.5K 0.39% 63
2020
Q1
$4.59M Sell
31,146
-1,811
-5% -$288K 0.37% 68
2019
Q4
$5.11M Sell
32,957
-1,639
-5% -$236K 0.32% 83
2019
Q3
$4.67M Sell
34,596
-500
-1% -$65.5K 0.31% 88
2019
Q2
$4.28M Sell
35,096
-560
-2% -$62K 0.3% 93
2019
Q1
$3.71M Sell
35,656
-580
-2% -$59.9K 0.27% 101
2018
Q4
$4.13M Buy
36,236
+40
+0.1% +$4.29K 0.35% 77
2018
Q3
$4.17M Sell
36,196
-1,190
-3% -$130K 0.31% 87
2018
Q2
$3.87M Sell
37,386
-395
-1% -$40K 0.31% 82
2018
Q1
$3.72M Sell
37,781
-24
-0.1% -$2.27K 0.31% 87
2017
Q4
$3.2M Sell
37,805
-730
-2% -$60.3K 0.27% 98
2017
Q3
$2.97M Buy
38,535
+2,545
+7% +$195K 0.25% 114
2017
Q2
$2.8M Buy
35,990
+735
+2% +$52.6K 0.25% 114
2017
Q1
$2.54M Buy
35,255
+6,105
+21% +$422K 0.24% 120
2016
Q4
$1.81M Buy
+29,150
New +$1.79M 0.22% 118
2016
Q2
$1.62M Buy
25,620
+3,800
+17% +$224K 0.2% 135
2016
Q1
$1.26M Buy
21,820
+1,865
+9% +$106K 0.17% 150
2015
Q4
$1.07M Buy
19,955
+5,170
+35% +$291K 0.15% 150
2015
Q3
$728K Sell
14,785
-305
-2% -$16.4K 0.15% 145
2015
Q2
$764K Sell
15,090
-2,780
-16% -$175K 0.17% 142
2015
Q1
$1.28M Buy
+17,870
New +$1.16M 0.21% 126
2014
Q4
Sell
-14,785
Closed -$728K 739
2014
Q3
$728K Buy
+14,785
New +$753K 0.14% 145

Other funds holding RMD

MassMutual Private Wealth & Trust's RMD Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its ResMed (RMD) stake by 2.4% in Q2 2026, selling an estimated $335K and leaving 65,076 shares worth $12.7M. The position accounts for 0.33% of the portfolio, ranked #69.

MassMutual Private Wealth & Trust first reported a position in RMD in Q3 2014 and has held it in 46 quarters since. The position peaked at $19M in Q3 2025. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • MassMutual Private Wealth & Trust held 65,076 shares of ResMed worth $12.7M as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 1,618 ResMed shares in Q2 2026, an estimated $335K.
  • ResMed made up 0.33% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #69 holding.
  • MassMutual Private Wealth & Trust first reported a position in ResMed in Q3 2014 and has held it in 46 quarters since.
  • MassMutual Private Wealth & Trust's ResMed position peaked at $19M in Q3 2025.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.